Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (231-240 of 546) with videos related to

Pageof 55
Sort By:
Gene Therapy|January 27, 2019
Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expressionSarah Urnauer, Kathrin A Schmohl, Mariella Tutter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2016
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, et al.
Current Alzheimer Research|March 15, 2016
Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume EffectsMatthias Brendel, Veronika Reinisch, Eva Kalinowski, et al.
Gene Therapy|July 11, 2024
Correction: Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expressionSarah Urnauer, Kathrin A Schmohl, Mariella Tutter, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission TomographyLeonie Beyer, Matthias Brendel, Franziska Scheiwein, et al.
Radiation Oncology (London, England)|October 23, 2016
Suspected recurrence of brain metastases after focused high dose radiotherapy: can [<sup>18</sup>F]FET- PET overcome diagnostic uncertainties?Alexander Romagna, Marcus Unterrainer, Christine Schmid-Tannwald, et al.
EJNMMI Research|August 16, 2019
3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CTAstrid Gosewisch, Harun Ilhan, Sebastian Tattenberg, et al.
Biomedicines|December 23, 2022
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft TumorsJohannes Zellmer, Hsi-Yu Yen, Lena Kaiser, et al.
Endocrine-Related Cancer|October 28, 2020
Integrin αvβ3-dependent thyroid hormone effects on tumour proliferation and vascularisationKathrin A Schmohl, Yang Han, Mariella Tutter, et al.
Journal of Vestibular Research : Equilibrium & Orientation|January 8, 2015
Assessment of cerebral dopamine D 2/3 formula-receptors in patients with bilateral vestibular failureNathalie L Jansen, Regina Feuerecker, Sandra Becker-Bense, et al.
Pageof 55

Showing results (231-240 of 546) with videos related to

Sort By:
Pageof 55
Gene Therapy|January 27, 2019
Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expressionSarah Urnauer, Kathrin A Schmohl, Mariella Tutter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2016
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, et al.
Current Alzheimer Research|March 15, 2016
Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume EffectsMatthias Brendel, Veronika Reinisch, Eva Kalinowski, et al.
Gene Therapy|July 11, 2024
Correction: Dual-targeted NIS polyplexes-a theranostic strategy toward tumors with heterogeneous receptor expressionSarah Urnauer, Kathrin A Schmohl, Mariella Tutter, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2020
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission TomographyLeonie Beyer, Matthias Brendel, Franziska Scheiwein, et al.
Radiation Oncology (London, England)|October 23, 2016
Suspected recurrence of brain metastases after focused high dose radiotherapy: can [<sup>18</sup>F]FET- PET overcome diagnostic uncertainties?Alexander Romagna, Marcus Unterrainer, Christine Schmid-Tannwald, et al.
EJNMMI Research|August 16, 2019
3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CTAstrid Gosewisch, Harun Ilhan, Sebastian Tattenberg, et al.
Biomedicines|December 23, 2022
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft TumorsJohannes Zellmer, Hsi-Yu Yen, Lena Kaiser, et al.
Endocrine-Related Cancer|October 28, 2020
Integrin αvβ3-dependent thyroid hormone effects on tumour proliferation and vascularisationKathrin A Schmohl, Yang Han, Mariella Tutter, et al.
Journal of Vestibular Research : Equilibrium & Orientation|January 8, 2015
Assessment of cerebral dopamine D 2/3 formula-receptors in patients with bilateral vestibular failureNathalie L Jansen, Regina Feuerecker, Sandra Becker-Bense, et al.
Pageof 55